Acute promyelocytic leukemia (APL), characterized by the t(15;17) translocation leading to the PML-RARA fusion gene, has transformed into a highly curable form of AML with treatment using all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) [1,2]. Here, PML is linked to acute promyelocytic leukemia.